Gerresheimer AG / Analyst ratings
Price targets
Analyst ratings
8 analysts rated this company in the past 90 days. The average target price is €68.13, this is a change of +122.2% compared to the current price.
-
Hauck Aufhäuser IB maintains Gerresheimer at 'Buy' - Target 65 euros
HAMBURG (dpa-AFX Analyst) - Hauck Aufhäuser Investment Banking has maintained its "Buy" rating for Gerresheimer with a price target of €65. While the BaFin special audit is a further dampener of confidence, Alexander Galitsa wrote in his commentary published Thursday, the extent of any potentially necessary balance sheet reclassifications for the packaging specialist is ultimately very small. Galitsa is also counting on the sale of the molded glass business to reveal hidden value./ag/tih
Publication of the original study: September 25, 2025 / 8:16 a.m. / CET
First distribution of the original study: September 25, 2025 / 8:16 a.m. / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
arclays: Investor reaction to Gerresheimer exaggerated
LONDON (dpa-AFX Analyst) - Investors overreacted to the review of Gerresheimer by the German financial regulator BaFin on Wednesday, according to investment bank Barclays. While the experts see a further dampener of confidence, they expect the share price to recover after the slump. The review only affects less than 5 percent of sales and profits. However, despite the attractive valuation, the experts admit it will be difficult to attract new investors. Nevertheless, their rating remains "Overweight" with a price target of €64./ag/tav
Publication of the original study: September 24, 2025 / 9:38 a.m. / GMT
First distribution of the original study: September 24, 2025 / 9:38 a.m. / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Hauck Aufhäuser IB maintains Gerresheimer at 'Buy' - Target 65 euros
HAMBURG (dpa-AFX Analyst) - Hauck Aufhäuser Investment Banking has maintained its "Buy" rating for Gerresheimer with a price target of €65. The planned sale of the container glass business is extremely favorable news, wrote analyst Alexander Galitsa in a study published Tuesday. The battered share price of the specialty container manufacturer could receive new impetus as a result. A sale is likely to reduce the impact of the debt issue and shift the focus to valuation potential./rob/mf/tih
Publication of the original study: August 5, 2025 / 8:06 a.m. / Time zone not specified in the study
First distribution of the original study: August 5, 2025 / 8:21 a.m. / Time zone not specified in the study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer's 'Buy' rating - target 68 euros
NEW YORK (dpa-AFX Analyst) - The analyst firm Jefferies has maintained a "Buy" rating on the shares of specialty packaging manufacturer Gerresheimer with a price target of €68 following the announcement of the sale of its glass business. This follows a recent rating by James Vane-Tempest on Monday./rob/ajx/he
Publication of the original study: August 4, 2025 / 1:06 p.m. / Time zone not specified in the study. First distribution of the original study: August 4, 2025 / 1:06 p.m. / Time zone not specified in the study.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer's 'Buy' rating - target 68 euros
NEW YORK (dpa-AFX Analyser) - The analyst firm Jefferies has maintained its rating for Gerresheimer at "Buy" with a price target of 68 euros. After talks with financial investors regarding a potential takeover offer have ended and the strategic review of the molded glass business is now to be accelerated, the capital markets day in mid-October will be very important for the company's future share price performance, James Vane-Tempest wrote on Thursday./rob/mis/ag
Publication of the original study: July 17, 2025 / 2:50 a.m. / Time zone not specified in study
First distribution of the original study: July 17, 2025 / 2:50 a.m. / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
UBS lowers target for Gerresheimer to 75 euros - 'Buy'
ZURICH (dpa-AFX Analyst) - Swiss bank UBS has lowered its price target for Gerresheimer from EUR 97 to EUR 75, but maintained its "Buy" rating. Analyst Olivier Calvet factored the current headwinds for the specialty glass business Moulded Glass following the profit warning in June into his estimates on Monday. With his growth forecast of 6 percent, the expert is now at the lower end of the company's updated medium-term target range. He expects the operating margin to reach 22 percent by 2028, instead of the targeted 23 to 25 percent. However, Calvet currently sees only 3 percent growth priced into the shares from 2026 onwards./rob/ag/zb
Publication of the original study: July 14, 2025 / 2:27 a.m. / GMT
First distribution of the original study: July 14, 2025 / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank lowers target for Gerresheimer to 55 euros - 'Hold'
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research lowered its price target for Gerresheimer from €58 to €55, but maintained its "Hold" rating. He remains cautious with regard to the packaging manufacturer, Falko Friedrichs wrote in an assessment released Friday. The predictability of the necessary business acceleration in the second half of the year to achieve the annual targets appears limited, which increases the risks. This was reflected in the outlook lowered again the previous day. It is also unclear when there will be a recovery in the problem areas of the cosmetics business and the liquid container inventory reduction. The new medium-term targets for organic sales growth of 6 to 9 percent are also ambitious./gl/stk
Publication of the original study: July 11, 2025 / 7:58 a.m. / CET. First distribution of the original study: Date not specified in study / Time not specified in study / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research maintains Gerresheimer's 'Hold' rating - target 55 euros
HAMBURG (dpa-AFX Analyser) - The analyst firm Warburg Research has maintained its "Hold" rating for Gerresheimer with a price target of €55. Despite all the positive developments from management, these quarterly figures confirm the ongoing headwinds facing the specialty packaging manufacturer, Christian Ehmann wrote on Thursday. The containment solutions sector remains a hindrance to the company's development./rob/ag/zb
Publication of the original study: July 10, 2025 / 8:15 a.m. / Time zone not specified in the study
First distribution of the original study: Date not specified in the study / Time not specified in the study / Time zone not specified in the study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer's 'Buy' rating - target 68 euros
NEW YORK (dpa-AFX Analyst) - The analyst firm Jefferies has maintained its "Buy" rating for Gerresheimer with a price target of €68. The reduced medium-term forecast was to be expected given the current lack of predictability of the business, James Vane-Tempest wrote on Thursday after the interim report. In the conference call, he will focus on the exact reasons for the reduction as well as the potential from the GLP-1 class acceptance test business. Other topics include order timing due to capacity expansion and a recovery in the cosmetics sector./rob/ag/zb
Publication of the original study: July 10, 2025 / 2:32 a.m. / Time zone not specified in the study
First distribution of the original study: July 10, 2025 / 2:32 a.m. / Time zone not specified in the study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
UBS maintains Gerresheimer at 'Buy' - target 97 euros
ZURICH (dpa-AFX Analyst) - Swiss bank UBS has maintained its rating for Gerresheimer at "Buy" with a price target of EUR 97. As announced with the profit warning at the beginning of June, the medium-term targets have now also been adjusted – but only with regard to growth expectations, Olivier Calvet wrote on Thursday after the interim report. In summary, he sees no new negative aspects./rob/ag/zb
Publication of the original study: July 10, 2025 / 6:15 a.m. / GMT
First distribution of the original study: July 10, 2025 / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
JPMorgan maintains Gerresheimer at 'Overweight' - Target 108 euros
NEW YORK (dpa-AFX Analyst) - US bank JPMorgan has maintained its rating for Gerresheimer at "Overweight" with a price target of €108. At first glance, the new medium-term targets appear better than feared, David Adlington wrote on Thursday following the specialty packaging manufacturer's figures. However, given recent developments, skepticism is likely to prevail./rob/ag/zb
Publication of the original study: July 10, 2025 / 7:25 a.m. / BST
First distribution of the original study: July 10, 2025 / 7:25 a.m. / BST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Barclays lowers target for Gerresheimer to 64 euros - 'Overweight'
LONDON (dpa-AFX Analyst) - British investment bank Barclays has lowered its price target for Gerresheimer from €67 to €64, but maintained its "overweight" rating. Analyst Gaurav Jain does not expect any further surprises from the specialty packaging manufacturer following the profit warning. On Monday, it adjusted its earnings estimates downward in its outlook for the quarterly report due to currency effects./ag/gl
Publication of the original study: July 7, 2025 / 4:03 PM / GMT. First distribution of the original study: July 8, 2025 / 3:00 AM / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
JPMorgan maintains Gerresheimer at 'Overweight' - Target 108 euros
NEW YORK (dpa-AFX Analyst) - US bank JPMorgan has maintained its rating for Gerresheimer at "Overweight" with a price target of €108. Following the profit warning at the beginning of June, the quarterly report will focus on the new medium-term outlook and possible news regarding private equity interest in the specialty packaging manufacturer, David Adlington wrote in his outlook published on Friday. He still finds it confusing that the medium-term outlook is to be issued before the Capital Markets Day./rob/ag/gl
Publication of the original study: July 3, 2025 / 7:55 PM / BST First distribution of the original study: July 4, 2025 / 12:15 AM / BST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Hauck Aufhäuser IB maintains Gerresheimer at 'Buy' - Target 65 euros
HAMBURG (dpa-AFX Analyst) - Hauck Aufhäuser Investment Banking has maintained a "Buy" rating on Gerresheimer with a price target of €65. In a study published Monday, analyst Alexander Galitsa initially explained the reasons for the sharp decline in the specialty packaging manufacturer's share price despite ongoing discussions with potential takeover buyers. He pointed to the recent profit warning, weak free cash flow, increased capital expenditures, and partially weak operating businesses, which make debt a growing problem. However, he sees an opportunity for a turnaround, as a possible sale of the molded glass business, which is currently being examined, should enable significant value growth./rob/ck/tih
Publication of the original study: June 16, 2025 / 8:06 a.m. / Time zone not specified in the study. First distribution of the original study: June 16, 2025 / 8:23 a.m. / Time zone not specified in the study.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer's 'Buy' rating - target 68 euros
NEW YORK (dpa-AFX Analyst) - The research firm Jefferies has maintained its "Buy" rating for Gerresheimer with a price target of €68. Analyst James Vane-Tempest routinely commented on monthly price developments in the healthcare sector in his assessment published Friday. Gerresheimer stands out particularly in its tracking scheme due to its recent weak share price performance, which was accompanied by a lowered outlook./tih/ag
Publication of the original study: June 12, 2025 / 11:20 a.m. / ET
First distribution of the original study: June 12, 2025 / 7:00 p.m. / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research lowers Gerresheimer to 'Hold' - target 55 euros
HAMBURG (dpa-AFX Analyst) - Following a profit warning, the analyst firm Warburg Research has cut its price target for Gerresheimer shares from €106 to €55, downgrading the stock from "Buy" to "Hold." Analyst Christian Ehmann justified his move to the sidelines on Tuesday with execution issues, short-term weak demand, and integration uncertainties. Until further margin development and the strategic repositioning become clearer, there is little potential. Not only did he cut his estimates, but he also increased the risk discount in the valuation model./ag/tih
Publication of the original study: June 3, 2025 / 8:15 a.m. / CEST
First distribution of the original study: Date not specified in study / Time not specified in study / CEST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank lowers Gerresheimer to 'Hold' and target to 58 euros
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research has cut its price target for Gerresheimer shares from €94 to €58, downgrading the stock from "Buy" to "Hold." In his reassessment published Tuesday, analyst Falko Friedrichs finds it puzzling how demand problems alone could have led to another profit warning from the packaging manufacturer. After all, the targets were lowered just three months ago, when the market was already showing signs of weakness. This suggests that the management team is having difficulty making forecasts./tih/ag
Publication of the original study: June 3, 2025 / Time not specified in the study / CET
First distribution of the original study: June 3, 2025 / 7:50 a.m. / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg lowers Gerresheimer to 'Hold' and target to 55 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has lowered its price target for Gerresheimer from €95 to €55 and downgraded the shares from "Buy" to "Hold." Following another profit warning, analyst Victoria Lambert, according to her reassessment published on Wednesday, lacks reliability at the packaging manufacturer. Management's credibility appears to be approaching a historic low. Shares are likely to remain under pressure as long as there is no activity regarding takeover interest from financial investors or a new strategy for the glass business has been established./rob/tih/ag
Publication of the original study: June 3, 2025 / 4:21 PM / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies lowers target for Gerresheimer to 68 euros - 'Buy'
NEW YORK (dpa-AFX Analyser) - The analyst firm Jefferies has lowered the price target for Gerresheimer from 86 to 68 euros, but left the rating at "Buy". James Vane-Tempest wrote in a response released Tuesday that he had revised his estimates for the pharmaceutical and cosmetics packaging manufacturer downward following the company's renewed forecast cut./rob/gl/men
Publication of the original study: June 3, 2025 / 3:48 p.m. / Time zone not specified in the study. First distribution of the original study: June 3, 2025 / 3:48 p.m. / Time zone not specified in the study.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Hauck Aufhäuser IB lowers Gerresheimer target to 65 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - Hauck Aufhäuser Investment Banking lowered its price target for Gerresheimer from €95 to €65 following cuts to its corporate targets, but maintained its "Buy" rating. In his reassessment, published on Tuesday, Alexander Galitsa also pointed to the specialty packaging manufacturer's "effectively suspended dividend." He noted that competitors Stevanato and Schott Pharma returned to healthy growth in the second quarter. Coupled with the company's debt, the company's operational weakness is cause for concern./rob/tih/ag
Publication of the original study: June 3, 2025 / 8:30 a.m. / Time zone not specified in the study
First distribution of the original study: June 3, 2025 / 8:33 a.m. / Time zone not specified in the study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
JPMorgan lowers target for Gerresheimer to 108 euros - 'Overweight'
NEW YORK (dpa-AFX Analyst) - US bank JPMorgan lowered its price target for Gerresheimer from €122.50 to €108 and maintained its "Overweight" rating. The specialty packaging manufacturer's performance has gone from "bad to worse," David Adlington wrote on Monday evening following the renewed profit warning. He cut his earnings estimates by 21 percent./ag/zb
Publication of the original study: June 2, 2025 / 8:48 PM / BST
First distribution of the original study: June 3, 2025 / 12:15 AM / BST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Barclays lowers target for Gerresheimer to 67 euros - 'Overweight'
LONDON (dpa-AFX Analyst) - British investment bank Barclays lowered its price target for Gerresheimer from €80 to €67 following another profit warning, but maintained its "overweight" rating. Gaurav Jain adjusted his estimates to reflect the company's new targets. The analysts are maintaining their recommendation for the specialty packaging manufacturer due to the allegedly low valuation and a possible takeover by private equity investors./ag/ajx
Publication of the original study: June 2, 2025 / 8:06 PM / GMT
First distribution of the original study: June 3, 2025 / 3:00 AM / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
UBS maintains Gerresheimer at 'Buy' - target 97 euros
ZURICH (dpa-AFX Analyst) - Swiss bank UBS has maintained its "Buy" rating for Gerresheimer with a price target of €97. The specialty packaging manufacturer's profit warning was a negative surprise, wrote Olivier Calvet in his first commentary on Monday evening. He considers the weakness in the containment solutions segment for oral liquid medications particularly surprising. This is a new aspect./rob/ag/tih
Publication of the original study: June 2, 2025 / 10:08 PM / GMT
First distribution of the original study: June 2, 2025 / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer's 'Buy' rating - target €86
NEW YORK (dpa-AFX Analyst) - The analyst firm Jefferies has maintained its rating for Gerresheimer at "Buy" with a price target of €86. Following the specialty packaging manufacturer's forecast reduction, analyst James Vane-Tempest sees a need for an 8 percent adjustment in the earnings consensus – assuming the midpoint of the targeted growth range with a margin of 20 percent. He wrote this on Monday in his first reaction to the news./ag/ajx
Publication of the original study: June 2, 2025 / 7:33 a.m. / ET
First distribution of the original study: June 2, 2025 / 7:33 a.m. / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg maintains Gerresheimer's 'Buy' rating - target 95 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained its "Buy" rating for Gerresheimer with a price target of €95. The tone at the Berenberg MedTech investor conference in Manhattan was surprisingly positive despite the adverse environment, wrote Sam England in his commentary published Thursday. Most companies are optimistic about the second half of the year and initially expect only limited financial burdens from tariffs./ag/mis
Publication of the original study: May 28, 2025 / 4:43 PM / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Barclays lowers target for Gerresheimer to 80 euros - 'Overweight'
LONDON (dpa-AFX Analyst) - British investment bank Barclays has lowered its price target for Gerresheimer from €95 to €80, but maintained its rating at "Overweight." Gaurav Jain wrote in his industry commentary published Tuesday that the specialty packaging manufacturer must scale back its long-term growth ambitions. He also sees risks to its annual targets. However, the valuation of the shares is comparatively low./ag/ajx
Publication of the original study: May 19, 2025 / 9:26 PM / GMT
First distribution of the original study: May 20, 2025 / 3:00 AM / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies lowers target for Gerresheimer to 86 euros - 'Buy'
NEW YORK (dpa-AFX Analyst) - The analyst firm Jefferies lowered its price target for Gerresheimer from €93 to €86, but maintained its "Buy" rating. Analyst James Vane-Tempest cut his revenue and earnings estimates on Wednesday following the company's quarterly results. However, a conversation with the CEO has reassured the audience regarding long-term trends./ag/mis
Publication of the original study: April 16, 2025 / 2:26 PM / ET
First distribution of the original study: April 16, 2025 / 7:01 PM / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank Research maintains Gerresheimer's 'Buy' rating; target EUR 94
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research has maintained a "Buy" rating on Gerresheimer with a price target of €94. The specialty packaging manufacturer's recently published quarterly figures were weak, but the outlook was confirmed, wrote analyst Falko Friedrichs in a review published on Monday.
Publication of the original study: April 14, 2025 / 8:24 a.m. / CET. First distribution of the original study: Date not specified in study / Time not specified in study / CET.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Hauck Aufhäuser IB maintains Gerresheimer at 'Buy' - Target 95 euros
HAMBURG (dpa-AFX Analyst) - Hauck Aufhäuser Investment Banking has maintained its "Buy" rating for Gerresheimer with a price target of €95. Talks about a takeover by the manufacturer of specialty packaging appear to be continuing, analyst Alexander Galitsa wrote in a report released Monday. This could result in a binding or non-binding purchase offer to shareholders. Speculation about a takeover price of approximately €90 per share made a potential offer extremely attractive.
Publication of the original study: April 13, 2025 / 6:48 PM / CEST
First distribution of the original study: April 14, 2025 / 8:11 AM / CEST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer's 'Buy' rating - target EUR 93
NEW YORK (dpa-AFX Analyst) - Following the company's first-quarter figures, analyst Jefferies maintained its "Buy" rating for Gerresheimer with a price target of €93. The pharmaceutical and cosmetics packaging manufacturer's revenues were slightly below market expectations, but the overall development is consistent with the company's announcement of a sluggish start to the fiscal year, analyst James Vane-Tempest wrote in a report released Friday. The annual outlook was also confirmed./mis/la
Publication of the original study: April 11, 2025 / 2:01 a.m. / ET First distribution of the original study: April 11, 2025 / 2:01 a.m. / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research maintains Gerresheimer's 'Buy' rating - target 106 euros
HAMBURG (dpa-AFX Analyst) - Following the first-quarter results, the analyst firm Warburg Research has maintained its rating for Gerresheimer at "Buy" with a price target of €106. The pharmaceutical and cosmetics packaging manufacturer performed as expected, wrote analyst Christian Ehmann in a study published Friday. Business is now expected to accelerate from the second quarter of the year. It is encouraging that the positive effects of the product mix are already showing initial signs of effectiveness./la/nas
Publication of the original study: April 11, 2025 / 8:15 a.m. / CEST. First distribution of the original study: Date not specified in study / Time not specified in study / CEST.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank maintains Gerresheimer's 'Buy' rating - target EUR 94
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research has maintained its "Buy" rating for Gerresheimer ahead of its quarterly results, with a price target of €94. The specialty packaging manufacturer likely had a weak start to the year, wrote analyst Falko Friedrichs in an outlook published on Tuesday. He expects a six percent decline in revenue./edh/bek
Publication of the original study: March 25, 2025 / Time not specified in study / CET
First distribution of the original study: March 25, 2025 / 7:55 a.m. / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
UBS lowers target for Gerresheimer to 106 euros - 'Buy'
ZURICH (dpa-AFX Analyst) - Swiss bank UBS lowered its price target for Gerresheimer from EUR 116 to EUR 106, but maintained its "Buy" rating. Analyst Olivier Calvet lowered his earnings estimates on Wednesday in his review of the previous year's results, a presentation at the UBS Healthcare Conference, and a discussion with an industry executive. Gerresheimer remains an attractive investment for him even in its own right./ag/edh
Publication of the original study: March 19, 2025 / 6:21 a.m. / GMT
First distribution of the original study: March 19, 2025 / 6:21 a.m. / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg maintains Gerresheimer's 'Buy' rating - target 110 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained its "Buy" rating for Gerresheimer with a price target of €110. After a bumpy second half of the year, the packaging manufacturer's outlook appears mixed, wrote analyst Victoria Lambert in a study published Thursday. She cut her earnings per share estimate for this year due to higher financing costs. However, the large valuation gap compared to competitor stocks continues to support a buy recommendation./tih/gl
Publication of the original study: March 12, 2025 / 5:33 PM / GMT. First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research lowers target for Gerresheimer to 106 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research has lowered its price target for Gerresheimer from €113 to €106, but maintained its "Buy" rating. The transformation into a highly profitable specialty glass provider is accelerating, wrote analyst Christian Ehmann in his review of mixed quarterly figures released on Monday./ag/nas
Publication of the original study: March 3, 2025 / 8:15 a.m. / CET
First distribution of the original study: Date not specified in study / Time not specified in study / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank lowers target for Gerresheimer to 94 euros - 'Buy'
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research lowered its price target for Gerresheimer from €96 to €94, but maintained its "Buy" rating. The subdued price reaction to the clouded outlook indicates that investors increasingly view a potential takeover of the specialty packaging manufacturer as a likely scenario, wrote analyst Falko Friedrichs in his commentary published on Monday. Despite his reduced forecasts, he still believes the stock is fundamentally undervalued./edh/ag
Publication of the original study: March 3, 2025 / Time not specified in the study / CET
First distribution of the original study: March 3, 2025 / 8:30 a.m. / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank Research maintains Gerresheimer's 'Buy' rating
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research has maintained a "Buy" rating on Gerresheimer with a price target of €96. The specialty packaging manufacturer reported a mixed final quarter of 2024 and issued a disappointing outlook, wrote analyst Falko Friedrichs in a review published Thursday./gl/edh
Publication of the original study: February 27, 2025 / 8:10 a.m. / CET First distribution of the original study: Date not specified in study / Time not specified in study / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Hauck Aufhäuser IB lowers target for Gerresheimer - 'Buy'
HAMBURG (dpa-AFX Analyst) - Hauck Aufhäuser Investment Banking lowered its price target for Gerresheimer from €105 to €95 following the company's earnings results, but maintained its "Buy" rating. The specialty packaging manufacturer's revenue target for the new 2024/25 financial year is disappointing, analyst Alexander Galitsa wrote in a report released Thursday. However, the focus is currently primarily on the ongoing takeover discussions involving numerous interested parties./ck/la
Publication of the original study: February 27, 2025 / 7:58 a.m. / CET. First distribution of the original study: February 27, 2025 / 8:19 a.m. / CET.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research maintains Gerresheimer's 'Buy' rating - target 113 euros
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research has maintained its rating for Gerresheimer at "Buy" after the company's earnings release, with a price target of €113. The specialty packaging manufacturer's fourth quarter was weaker than expected, wrote analyst Christian Ehmann in a quick assessment published Wednesday. The outlook was in line with expectations./mf/edh
Publication of the original study: February 26, 2025 / 8:15 a.m. / CET
First distribution of the original study: Date not specified in study / Time not specified in study / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
UBS maintains Gerresheimer's 'Buy' rating - target 116 euros
ZURICH (dpa-AFX Analyst) - Swiss bank UBS has maintained a "buy" rating on Gerresheimer following its earnings release, with a price target of EUR 116. After the mixed final quarter of 2024, the focus is now on the specialty packaging manufacturer's new outlook, analyst Olivier Calvet wrote in an initial reaction on Wednesday. It is not comparable with the previous targets, as it, like the revised medium-term outlook, now takes into account the contribution of the acquired Bormioli Pharma./gl/edh
Publication of the original study: February 26, 2025 / 07:22 / GMT First distribution of the original study: February 26, 2025 / 07:22 / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains 'Buy' rating on Gerresheimer after figures
NEW YORK (dpa-AFX Analyst) - Research firm Jefferies has maintained a "Buy" rating on Gerresheimer with a price target of €93. The specialty packaging manufacturer's revenues last year were slightly below expectations, but the focus should be on the lowered forecasts for 2025 and the medium-term outlook, analyst James Vane-Tempest wrote in a flash assessment published Wednesday. These forecasts now include the acquired Bormioli Pharma, which dilutes the group's growth. Apart from that, the recent potential takeover offer from financial investors should provide support for the stock. He expects further details in the upcoming conference call.
Publication of the original study: February 26, 2025 / 2:28 a.m. / ET First distribution of the original study: February 26, 2025 / 2:28 a.m. / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank lowers target for Gerresheimer to 96 euros - 'Buy'
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research lowered its price target for Gerresheimer from €110 to €96 in a preview of the company's fourth-quarter results. However, analyst Falko Friedrichs maintained his rating at "Buy" on Thursday. He expects the packaging manufacturer's target range for operating revenue growth in 2025 to be reduced from 7 to 10 percent to 5 to 8 percent. Headwinds from the reduction of inventories are still noticeable./tih/gl
Publication of the original study: February 20, 2025 / Time not specified in the study / CET. First distribution of the original study: February 20, 2025 / 7:48 a.m. / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
UBS lowers target for Gerresheimer to 116 euros - 'Buy'
ZURICH (dpa-AFX Analyst) - Swiss bank UBS has lowered its price target for Gerresheimer from €132 to €116, but maintained its "Buy" rating. Following study results on the weight-loss drug Cagrisema and further information from pharmaceutical company Novo Nordisk, analyst Olivier Calvet wrote in his commentary published Tuesday that he has lowered his revenue estimates for the pharmaceutical packaging manufacturer's GLP-1 syringe business. He also cut his earnings forecasts. The company's still high debt level could also pose a hurdle to the interest from financial investors that emerged last week. Thanks to the sector discount, Gerresheimer is also attractively valued as a standalone company, the expert continued./gl/ag
Publication of the original study: February 11, 2025 / 02:05 / GMT. First distribution of the original study: February 11, 2025 / 02:05 / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Hauck Aufhäuser IB maintains Gerresheimer at 'Buy' - Target 105 euros
HAMBURG (dpa-AFX Analyst) - Hauck Aufhäuser Investment Banking has maintained its rating for Gerresheimer at "Buy" with a price target of €105. The interest of private equity firms in the manufacturer of specialty packaging for the pharmaceutical and cosmetics industries, which became known before the weekend, is no surprise, wrote analyst Alexander Galitsa in a study released Monday. A takeover offer appears possible given the decline in the share price and the value potential in the event of a company split./bek/mis
Publication of the original study: February 10, 2025 / 7:49 a.m. / CET
First distribution of the original study: February 10, 2025 / 7:58 a.m. / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg maintains Gerresheimer's 'Buy' rating - target 110 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained a "Buy" rating on Gerresheimer with a price target of €110. Despite the profit warning and disappointing data on Novo Nordisk's obesity drug Cagrisema, Gerresheimer's medium-term target of peak sales of €350 million or more in the weight-loss products business has not changed, analyst Victoria Lambert wrote in a study published Thursday. The positive impact of contracts for such products, as well as the high medium-term profit growth potential, are not adequately taken into account when considering the valuation compared to the competition./ajx/nas
Publication of the original study: January 29, 2025 / 5:44 PM / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies upgrades Gerresheimer to 'Buy' - close to valuation floor
NEW YORK (dpa-AFX Analyst) - The research firm Jefferies has maintained its "Buy" rating for Gerresheimer with a price target of €93. The syringe and ampoule supplier's share price decline is reacting very sensitively to disappointing Cagrisema data from its customer Novo Nordisk, analyst James Vane-Tempest wrote on Friday. The weight-loss drug, with its dual-chamber syringe, is immensely important for Gerresheimer's potential. However, Vane-Tempest stated that the price slide has already brought the shares very close to the valuation floor he calculated at around €62./ag/ajx
Publication of the original study: December 20, 2024 / 6:38 a.m. / ET
First distribution of the original study: December 20, 2024 / 6:38 a.m. / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer's 'Buy' rating - target EUR 93
NEW YORK (dpa-AFX Analyst) - The analyst firm Jefferies has maintained a "Buy" rating on Gerresheimer with a price target of €93. With a view to the completion of the acquisition of Bormioli Pharma, analyst James Vane-Tempest addressed the pharmaceutical packaging manufacturer's targets for the new fiscal year and its medium-term outlook in a report published Wednesday. His forecasts for the adjusted operating profit margin (EBITDA margin) are below current corporate planning, and he assumes that Gerresheimer will demonstrate a more conservative target-setting policy when it announces its financial year figures at the end of February./gl/mis
Publication of the original study: December 11, 2024 / 4:03 a.m. / ET First distribution of the original study: December 11, 2024 / 4:03 a.m. / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
UBS maintains Gerresheimer's 'Buy' rating - target 132 euros
ZURICH (dpa-AFX Analyst) - Swiss bank UBS has maintained its "Buy" rating for Gerresheimer with a price target of €132. The study data on Novo Nordisk's weight-loss drug CagriSema could become a price driver for the packaging and syringe specialist as a key supplier, wrote analyst Olivier Calvet in his assessment published Friday. He favors Gerresheimer over Ypsomed in this regard. Schott Pharma and Stevanto are not directly affected./ag/edh
Publication of the original study: November 29, 2024 / 3:08 a.m. / GMT
First distribution of the original study: November 29, 2024 / 3:08 a.m. / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg lowers target for Gerresheimer to 110 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has lowered its price target for Gerresheimer from €125 to €110 following the company's recent profit warning, but has maintained its "Buy" rating. In discussions with investors in the specialty packaging manufacturer, three major concerns have emerged, analyst Victoria Lambert wrote in her commentary published Friday. These include the late timing of the warning, the credibility of management, and the lack of transparency./edh/ag
Publication of the original study: October 3, 2024 / 4:21 PM / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
UBS lowers target for Gerresheimer to 132 euros - 'Buy'
ZURICH (dpa-AFX Analyst) - Swiss bank UBS has lowered its price target for Gerresheimer from €144 to €132, but maintained its "Buy" rating. Analyst Olivier Calvet adjusted his estimates in his commentary published on Tuesday to reflect the specialty packaging manufacturer's lowered forecast./ag/la
Publication of the original study: October 1, 2024 / 8:29 a.m. / GMT
First distribution of the original study: October 1, 2024 / 8:29 a.m. / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank Research lowers Gerresheimer price target - maintains 'Buy'
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research lowered its price target for Gerresheimer from €130 to €110, but maintained its "Buy" rating. Analyst Falko Friedrichs sees an attractive buying opportunity in the wake of the price slide following the forecast cuts. The necessary adjustments to the market consensus appear rather moderate, he wrote in his commentary published on Tuesday. He also considers the new targets for 2025 to be extremely cautious./ag/zb
Publication of the original study: October 1, 2024 / Time not specified in the study / CET
First distribution of the original study: October 1, 2024 / 8:13 a.m. / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research lowers target for Gerresheimer - 'Buy'
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research has lowered its price target for Gerresheimer from €133 to €131, but maintained its "Buy" rating. Compared to the extent of the forecast cuts, the price decline appears excessive, wrote analyst Christian Ehmann in his commentary published on Tuesday. He continues to see a robust market environment and strong growth drivers. Ehmann advises taking advantage of the price weakness to buy./ag/zb
Publication of the original study: October 1, 2024 / 8:15 a.m. / CEST
First distribution of the original study: Date not specified in study / Time not specified in study / CEST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Hauck Aufhäuser IB lowers target for Gerresheimer - 'Buy'
HAMBURG (dpa-AFX Analyst) - Hauck Aufhäuser Investment Banking lowered its price target for Gerresheimer from €122 to €105, but maintained its "Buy" rating. Analyst Alexander Galitsa adjusted his estimates in his commentary published on Tuesday to reflect the forecast cuts. Sentiment is likely to remain subdued for the time being. Ultimately, however, the price decline is excessive given the attractive medium-term potential./ag/zb
Publication of the original study: October 1, 2024 / 8:59 a.m. / CEST
First distribution of the original study: October 1, 2024 / 8:59 a.m. / CEST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Oddo BHF downgrades Gerresheimer to 'Neutral'
FRANKFURT (dpa-AFX Analyst) - Investment bank Oddo BHF has downgraded Gerresheimer from "Outperform" to "Neutral" following a downgraded outlook for the specialty packaging manufacturer and lowered its price target from €124 to €93. The cut for 2025 is even more severe than the one for the current year, analyst Oliver Metzger wrote in his commentary published on Tuesday. He significantly cut his earnings estimates from 2025 onwards and sees no positive price drivers./ag/edh
Publication of the original study: October 1, 2024 / 12:24 AM / CET
First distribution of the original study: October 1, 2024 / 8:19 AM / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer at 'Buy' - target 121 euros
NEW YORK (dpa-AFX Analyser) - The analyst firm Jefferies has maintained its rating for Gerresheimer at "Buy" with a price target of 121 euros following a profit warning from the pharmaceutical packaging manufacturer. Consensus estimates for operating profit (EBITDA) are now expected to decline by three percent for 2024, and slightly more for 2025, wrote analyst James Vane-Tempest in a study released Monday./ajx/he
Publication of the original study: September 30, 2024 / 11:37 a.m. / ET First distribution of the original study: September 30, 2024 / 11:37 a.m. / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research lowers target for Gerresheimer - 'Buy'
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research has lowered its price target for Gerresheimer from €140 to €133, but maintained its rating at "Buy." The recovery from the inventory reduction is likely to be more sluggish than expected, wrote analyst Christian Ehmann in his outlook for the third-quarter report, published on Monday./ag/ajx
Publication of the original study: September 23, 2024 / 8:15 a.m. / CEST
First distribution of the original study: Date not specified in study / Time not specified in study / CEST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer at 'Buy' - target 121 euros
NEW YORK (dpa-AFX Analyst) - The analyst firm Jefferies has maintained a "Buy" rating on pharmaceutical packaging manufacturer Gerresheimer with a price target of €121. When the company releases its third-quarter results on October 10, investors will likely focus on whether statements about the final quarter imply that the company's annual targets will be met, wrote analyst James Vane-Tempest in an outlook published Tuesday. Recent statements from Gerresheimer and competitors indicate that the reduction in inventories, which had been the biggest obstacle in the first half of the year, is easing. The expert assumes that Gerresheimer will reach the lower end of its growth target range./gl/nas
Publication of the original study: September 17, 2024 / 2:01 PM / ET. First distribution of the original study: September 17, 2024 / 2:01 PM / ET.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank Research maintains Gerresheimer's 'Buy' rating
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research has maintained its "Buy" rating for Gerresheimer with a price target of €130. In his outlook for the quarterly report published on Monday, analyst Falko Friedrichs expects solid results and a confirmation of the annual targets./ag/la
Publication of the original study: September 16, 2024 / Time not specified in study / CET
First distribution of the original study: September 16, 2024 / 8:05 a.m. / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg maintains Gerresheimer's 'Buy' rating - target 125 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained its "Buy" rating for Gerresheimer with a price target of €125. Medical technology companies are back on track after a weak previous year, the experts wrote in their industry commentary published on Wednesday. Their favorites for the remainder of 2024 and into the new year are Fresenius, Alcon, and Biomerieux among the large caps. Among the small caps, they are focusing primarily on Advanced Medical Solutions, Hikma, and Stratec./ag/zb
Publication of the original study: September 10, 2024 / 4:56 PM / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies maintains Gerresheimer at 'Buy' - target 121 euros
NEW YORK (dpa-AFX Analyst) - The analyst firm Jefferies has maintained its rating for Gerresheimer at "Buy" with a price target of €121. The pharmaceutical packaging manufacturer's management is radiating confidence toward the end of the year, analyst James Vane-Tempest wrote on Tuesday after a meeting with the CFO./ag/la
Publication of the original study: September 10, 2024 / 3:50 p.m. / ET First distribution of the original study: September 10, 2024 / 8:00 p.m. / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Jefferies lowers target for Gerresheimer to 121 euros - 'Buy'
NEW YORK (dpa-AFX Analyst) - The analyst firm Jefferies lowered its price target for Gerresheimer from €128 to €121, but maintained its "Buy" rating. The pharmaceutical packaging manufacturer continues to struggle with customers' inventory reductions, analyst James Vane-Tempest wrote in a report released Thursday. Average analyst expectations are at the lower end of the company's targets for 2024. However, growth in the coming year could be boosted by delayed deliveries this year./niw/edh
Publication of the original study: August 14, 2024 / 12:20 PM / ET
First distribution of the original study: August 14, 2024 / 7:00 PM / ET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.